Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for Incannex Healthcare (IXHL) over the last 3 years, with Q3 2025 value amounting to $118173.0.

  • Incannex Healthcare's Gains from Investment Securities fell 4971.53% to $118173.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $118173.0, marking a year-over-year decrease of 4971.53%. This contributed to the annual value of $227508.0 for FY2025, which is 319.14% down from last year.
  • According to the latest figures from Q3 2025, Incannex Healthcare's Gains from Investment Securities is $118173.0, which was down 4971.53% from $23.6 million recorded in Q2 2025.
  • In the past 5 years, Incannex Healthcare's Gains from Investment Securities registered a high of $23.6 million during Q2 2025, and its lowest value of $118173.0 during Q3 2025.
  • In the last 3 years, Incannex Healthcare's Gains from Investment Securities had a median value of $235008.0 in 2024 and averaged $3.2 million.
  • Data for Incannex Healthcare's Gains from Investment Securities shows a peak YoY increase of 996178.51% (in 2025) and a maximum YoY decrease of 4971.53% (in 2025) over the last 5 years.
  • Incannex Healthcare's Gains from Investment Securities (Quarter) stood at $349500.0 in 2023, then plummeted by 32.76% to $235008.0 in 2024, then plummeted by 49.72% to $118173.0 in 2025.
  • Its Gains from Investment Securities stands at $118173.0 for Q3 2025, versus $23.6 million for Q2 2025 and $235008.0 for Q1 2025.